This inventor holds 1 USPTO granted patent and 7 published patent applications and 1 EPO patent. Top assignee: Hiroshi Kawamoto. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Yoshimoto Katsura in Stem Cell Research
Introduction
Yoshimoto Katsura is a prominent inventor based in Abiko, Japan. He has made significant contributions to the field of immunotherapy through his innovative research and patents. His work focuses on the development of methods for establishing pluripotent stem cells that can be utilized in targeted therapies.
Latest Patents
Yoshimoto Katsura holds a patent for a method aimed at inducing T cells for cell-based immunotherapy. The patent, titled "Method for establishing pluripotent stem cells bearing genes encoding antigen specific T cell receptor," outlines a two-step process. The first step involves providing human pluripotent stem cells that carry genes encoding a T cell receptor specific for a desired antigen. The second step details the induction of T cells from these pluripotent stem cells. This innovative approach has the potential to enhance the effectiveness of immunotherapy by utilizing tailored T cells.
Career Highlights
Throughout his career, Yoshimoto Katsura has demonstrated a commitment to advancing medical science. His work has not only contributed to the understanding of pluripotent stem cells but has also paved the way for new therapeutic strategies in treating various diseases. His dedication to research and innovation has established him as a key figure in the field.
Collaborations
Yoshimoto collaborates with notable colleagues, including Hiroshi Kawamoto and Kyoko Masuda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Yoshimoto Katsura's contributions to stem cell research and immunotherapy exemplify the importance of innovation in medicine. His patented methods represent a significant advancement in the field, showcasing the potential of pluripotent stem cells in developing targeted therapies. The ongoing collaboration with his colleagues continues to drive progress in this vital area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile